Skip to main content

Table 4 Literature review of studies that have addressed ethnycity related differences according to phenotype and outcome of BD [7, 8, 10, 11, 1316]

From: Ethnicity and association with disease manifestations and mortality in Behçet’s disease

First author

Country

Year of publication

Nb of patients

Ethnicity

Observations*

Wechsler

Paris (France)

1988

196

French Men (n = 36) and North African men (n = 160).

No significant difference

Zouboulis

Allemangne

1997

196

Allemands (n = 82), Immigrés Turques (n = 86) patients originaires de pays étrangers autres (n = 28)

Plus d’atteintes oculaires chez les patients du Sud-Est de l'Europe (Italie, Gèce) et de Turquie. 25% des patients avec évolution défavorable, 3 décès, tous Allemands.

Zouboulis

Germany

1997

196

German (n = 82), Turkish immigrants (n = 86), and patients from other foreign countries (n = 28)

Ocular disease is more frequent in South-Eastern European patients and in Turkish immigrants.

Muhaya

Kurume (Japan) London (England)

2000

54

Japanese (n = 35) and British (n = 19) (including: 12 caucasians, 5 Middle Eastern, 1 African, 1 Asian)

Kurume patients have more active anterior uveitis and more posterior uveitis than London patients.

Krause

Tel Aviv (Israel)

2001

100

Jewish patients (n = 66) (most of them originated from Iran/Iraq, Turkey and North African countries) and Arabic patients (n = 34)

Arabic patients have more severe ocular diseases. Jewish patients from North African countries have higher disease severity score.

Kotter

Tübingen (Germany)

2004

65

German (n = 32) and Turkish descents (n = 33)

No significant difference

Rozenbaum

Northern area of Israel

2007

53

Arabs (n = 30) and Druzes (n = 23)

Higher frequency of uveitis, of deep vein thrombosis, and of CNS involvement, and a higher global severity score in Arabs.

Mahr

Seine-Saint-Denis County (France)

2008

79

European patients (n = 19) and non-European patients (n = 60).

No significant difference

Mohammad

Skåne (Sweden)

2012

40

Swedish ancestry (n = 12) and non-Swedish ancestry (28/40, 70%) [Middle East (n = 15), Africa (n = 2), East Asia (n = 2); Turkey (n = 2), Central and Eastern Europe (n = 6)]

No significant difference

  1. *Difference with respect to phenotype or outcome of BD. CNS, central nervous system.